Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Sleep Disturbances: An Exploratory Study

被引：0
|
作者：
Krystal, Andrew [1 ]
Mittoux, Aurelia [2 ]
Meisels, Peter [2 ]
Baker, Ross [3 ]
机构：
[1] Duke Univ Hosp, Psychiat Brain Stimulat & Neurophysiol, Durham, NC USA
[2] H Lundbeck & Co AS, Clin, Valby, Denmark
[3] Otsuka Pharmaceut Dev & Commercializat Inc, CNS Global Med Affairs, Princeton, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2015年 / 77卷 / 09期
关键词：
brexpiprazole;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
173
引用
收藏
页码：64S / 65S
页数：2
相关论文
共 50 条
  • [1] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Irritability: An Exploratory Study
    Menard, Francois
    Fava, Maurizio
    Davidsen, Charlotte Kampp
    Baker, Ross A.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 65S - 65S
  • [2] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Anxiety Symptoms: An Exploratory Study
    Davis, Lori L.
    Ota, Ai
    Perry, Pamela
    Tsuneyoshi, Kana
    Weiller, Emmanuelle
    Baker, Ross
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 66S - 66S
  • [3] Adjunctive brexpiprazole (OPC-34712) in patients with major depressive disorder and anxiety symptoms: an exploratory study
    Davis, Lori
    Ota, Ai
    Perry, Pamela
    Tsuneyoshi, Kana
    Weiller, Emmanuelle
    Baker, Ross
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 101 - 102
  • [4] Adjunctive brexpiprazole (OPC-34712) in young patients with major depressive disorder who are working or at school: an exploratory study
    Baker, R.
    Ota, A.
    Perry, P.
    Tsuneyoshi, K.
    Weiller, E.
    Weisler, R.
    Sheehan, D. V.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S449 - S449
  • [5] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Irritability: A Post-Hoc Analysis on Symptoms of Anger
    Menard, Francois
    Davidsen, Charlotte Kampp
    Weiller, Emmanuelle
    Baker, Ross A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S175 - S176
  • [6] Efficacy and Safety of Adjunctive Brexpiprazole (OPC-34712) in Major Depressive Disorder: Results: of Two Pivotal Clinical Studies
    Thase, Michael
    Youakim, James
    Skuban, Alexander
    Hobart, Mary
    Zhang, Peter
    Legacy, Susan
    McQuade, Robert
    Nyilas, Margaretta
    Carson, William
    Sanchez, Raymond
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S357 - S357
  • [7] EFFICACY AND SAFETY OF ADJUNCTIVE BREXPIPRAZOLE (OPC-34712) IN MAJOR DEPRESSIVE DISORDER (MDD): A PHASE III, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Thase, M. E.
    Hobart, M.
    Augustine, C.
    Youakim, J.
    Zhang, P.
    Hefting, N.
    McQuade, R. D.
    Carson, W.
    Nyilas, M.
    Sanchez, R.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29
  • [8] Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
    Eriksson, Hans
    Weiller, Emmanuelle
    Weiss, Catherine
    Zhang, Peter
    Skuban, Aleksandar
    Thase, Michael E.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 102 - 102
  • [9] The Effect of Brexpiprazole (OPC-34712) versus Aripiprazole in Adult Patients with Acute Schizophrenia: An Exploratory Study
    Citrome, Leslie
    Ota, Ai
    Nagamizu, Kazuhiro
    Perry, Pamela
    Weiller, Emmanuelle
    Baker, Ross
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [10] The effect of brexpiprazole (OPC-34712) versus aripiprazole in adult patients with acute schizophrenia: an exploratory study
    Citrome, Leslie
    Ota, Ai
    Nagamizu, Kazuhiro
    Perry, Pamela
    Weiller, Emmanuelle
    Baker, Ross
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 189 - 190
12345